Uniting the ALS Community to Accelerate Progress in ALS Research, Care, and Advocacy
Arlington, VA (January 17, 2025) – The ALS Association is excited to announce the ALS Nexus 2025 conference, taking place August 11-14 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas, just outside of Dallas. Building on the success of last year’s inaugural event, ALS Nexus offers the rare opportunity for researchers, health care professionals, advocates, individuals living with ALS, and caregivers to come together to advance progress towards making ALS a livable disease.
Attendees will have the opportunity to connect with peers, other ALS organization partners, and gain insights from health care professionals, researchers, and ALS experts. Sessions will spotlight cutting-edge research, clinical advancements, advocacy strategies for increased funding and impactful legislation, and tools to shape the future of ALS care and patient support.
This year’s ALS Nexus conference offers exciting opportunities for attendees. Our goal is to make ALS Nexus as accessible and impactful as possible for everyone in the community. To honor the dedication of people living with ALS and their caregivers, we are offering special throwback pricing for both in-person and virtual attendance. For health care professionals, the conference will provide valuable Continuing Education Units (CEU) opportunities, with details on specific sessions coming soon.
Don’t miss your chance to connect, collaborate, and change the future of ALS. Space is limited, so early registration is encouraged. For more information on sponsorship opportunities, visit alsnexus.org.
About the ALS Association
The ALS Association is the largest ALS organization in the world. The ALS Association funds global research collaborations, assists people with ALS and their families through its nationwide network of care and certified clinical care centers, and advocates for better public policies for people with ALS. The ALS Association is working to make ALS a livable disease while urgently searching for new treatments and a cure. For more information about the ALS Association, visit our website at www.als.org.
About ALS
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. Over the course of the disease, people lose the ability to move, to speak, and eventually, to breathe. The disease is always fatal, usually within five years of diagnosis. Few treatment options exist, resulting in a high unmet need for new therapies to address functional deficits and disease progression